SCHEMBL2186104

SCHEMBL2186104

Oc1cccc(-c2ccccc2O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
HSD17B10 Q99714 2/20 0.62
HPGD P15428 1/20 0.62
BCL2L1 Q07817 1/20 0.62
ESR2 Q92731 3/20 0.62
HSD17B1 P14061 12/20 0.56
HSD17B2 P37059 12/20 0.56
CYP3A4 P08684 3/20 0.56
CYP2C9 P11712 2/20 0.56
ALOX5 P09917 1/20 0.56
PELI1 Q96FA3 1/20 0.51
ESR1 P03372 2/20 0.50
PTPN5 P54829 1/20 0.50
CA12 O43570 1/20 0.48
CA2 P00918 1/20 0.48
LMNA P02545 1/20 0.48
CA5A P35218 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29352158 1.00 ALDH1A1 (0.62) ALDH1A1HSD17B10HPGDBCL2L1ESR2
SCHEMBL31344495 1.00 ALDH1A1 (0.62) ALDH1A1HSD17B10HPGDBCL2L1ESR2
SCHEMBL31344497 1.00 ALDH1A1 (0.62) ALDH1A1HSD17B10HPGDBCL2L1ESR2
SCHEMBL29450254 1.00 ALDH1A1 (0.62) ALDH1A1HSD17B10HPGDBCL2L1ESR2
Butadiene SCHEMBL28294789 0.90 ESR2 (0.53) ALDH1A1HSD17B10HPGDBCL2L1ESR2
2-Phenylphenol SCHEMBL9169316 0.90 ALDH1A1 (0.68) ALDH1A1HSD17B10HPGDBCL2L1ESR2
2-Phenylphenol SCHEMBL27903087 0.89 ALDH1A1 (0.74) ALDH1A1HSD17B10HPGDBCL2L1ESR2
SCHEMBL23824845 0.88 ESR2 (0.59) ALDH1A1HSD17B10HPGDBCL2L1ESR2
SCHEMBL7570908 0.88 HPGD (0.71) ALDH1A1HSD17B10HPGDBCL2L1ESR2
SCHEMBL29944266 0.88 HPGD (0.71) ALDH1A1HSD17B10HPGDBCL2L1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9950979-B2 Method for producing asymmetrical biphenols using selenium dioxide EVONIK DEGUSSA GMBH (DE) 2018-04-24 US claimed
US-20170204031-A1 METHOD FOR PRODUCING ASYMMETRICAL BIPHENOLS USING SELENIUM DIOXIDE EVONIK DEGUSSA GMBH (DE) 2017-07-20 US claimed
US-20120322010-A1 Novel polymer composition and method of making the same SILECS OY (FI) 2012-12-20 US claimed
US-20060014876-A1 Thermally conductive liquid crystalline polymer compositions and articles formed therefrom SOLVAY ADVANCED POLYMERS, LLC 2006-01-19 US claimed
EP-1537189-A1 THERMALLY CONDUCTIVE LIQUID CRYSTALLINE POLYMER COMPOSITIONS AND ARTICLES FORMED THEREFROM Solvay Advanced Polymers, L.L.C. (US) 2005-06-08 EP claimed
WO-2004022669-A1 THERMALLY CONDUCTIVE LIQUID CRYSTALLINE POLYMER COMPOSITIONS AND ARTICLES FORMED THEREFROM SOLVAY ADVANCED POLYMERS, LLC (US) 2004-03-18 WO claimed
WO-1999032548-A1 POLYESTER COMPOSITION HAVING IMPROVED GAS BARRIER PROPERTIES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-07-01 WO claimed
EP-0451142-B1 LUBRICANT BLENDS HAVING HIGH VISCOSITY INDICES MOBIL OIL CORP (US) 1993-10-20 EP claimed
JP-5053315-A None JP disclosed
EP-3511375-B1 POLYCARBONATE RESIN COMPOSITION MITSUBISHI CHEM CORP (JP) 2026-04-08 EP disclosed
US-20260015500-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) 2026-01-15 US disclosed
EP-4674907-A1 RESIN COMPOSITION AND RESIN MOLDED ARTICLE Konica Minolta, Inc. (JP) 2026-01-07 EP disclosed
EP-3686231-B1 EPOXY RESIN, EPOXY RESIN COMPOSITION, EPOXY RESIN CURED PRODUCT AND COMPOSITE MATERIAL RESONAC CORP (JP) 2025-12-10 EP disclosed
EP-4173793-B1 METHOD FOR PRODUCING FLAME RETARDANT POLYCARBONATE RESIN COMPOSITION PELLET MITSUBISHI ENG PLASTICS CORP (JP) 2025-11-26 EP disclosed
EP-0402785-A1 Method for preparation of a moulded article from compressed particles and phenol resin HOECHST AKTIENGESELLSCHAFT (DE) 1990-12-19 EP disclosed
WO-1990012053-A1 PROCESS FOR THE PREPARATION OF POLYCARBONATE AND/OR POLYARYLATE BLOCK COPOLYMERS WITH POLY(ARYL ETHERS) AMOCO CORPORATION (US) 1990-10-18 WO disclosed
US-4533765-A REACTING WITH ALKALI METAL HYDROXIDE USING A NICKEL OR COBALT HYDROGENATION CATALYST AIR PRODUCTS AND CHEMICALS, INC. (US) 1985-08-06 US disclosed
US-4079040-A Sulfo-containing phenol-formaldehyde condensates CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) 1978-03-14 US disclosed
US-3933957-A Process for producing shaped articles from an acetylenic polymer GENERAL ELECTRIC COMPANY (US) 1976-01-20 US disclosed
JP-H00553315-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204031-A1 METHOD FOR PRODUCING ASYMMETRICAL BIPHENOLS USING SELENIUM DIOXIDE SELENOI, SCLY, GPX4 ALDH1A1 1215/4885HSD17B10 212/4885HPGD 659/4885
US-20260015500-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE CHERP, RER1, TAF1 ALDH1A1 2320/4885HSD17B10 3555/4885HPGD 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.